40 results on '"Barnette, Mary S."'
Search Results
2. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor
3. Phosphodiesterase IV Inhibitors as Therapy for Eosinophil-Induced Lung Injury in Asthma
4. A Noninvasive [99mTc]DTPA SPECT/CT Imaging Methodology as a Measure of Lung Permeability in a Guinea Pig Model of COPD
5. Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage
6. Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells
7. Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes
8. Cytokines modulate cilomilast response in lung fibroblasts
9. Chapter 11. Current and Potential New Therapies for Chronic Obstructive Pulmonary Disease
10. Progress in Drug Research
11. PDE4 Inhibitors Attenuate Fibroblast Chemotaxis and Contraction of Native Collagen Gels
12. Expression and Cellular Localization of the CC Chemokines PARC and ELC in Human Atherosclerotic Plaques
13. INDUCE-1: A phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with advanced solid tumors.
14. ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors.
15. A Noninvasive [99mTc]DTPA SPECT/CT Imaging Methodology as a Measure of Lung Permeability in a Guinea Pig Model of COPD
16. The Identification of a Novel Phosphodiesterase 4 Inhibitor, 1-Ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with Improved Therapeutic Index using Pica Feeding in Rats as a Measure of Emetogenicity
17. Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage
18. A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors
19. Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+T-Lymphocytes
20. Anti-Inflammatory and Utero-Relaxant Effects in Human Myometrium of New Generation Phosphodiesterase 4 Inhibitors
21. New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease
22. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B
23. 1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma
24. Salbutamol Up-regulates PDE4 Activity and Induces a Heterologous Desensitization of U937 Cells to Prostaglandin E2
25. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function
26. Change in Intracellular Cyclic Nucleotide Content Accompanies Relaxation of the Isolated Canine Internal Anal Sphincter
27. Inhibition of neuronally induced relaxation of canine lower esophageal sphincter by opioid peptides
28. PDE4 Inhibitors Attenuate Fibroblast Chemotaxis and Contraction of Native Collagen Gels.
29. Inhibition of Calmodulin-Stimulated Phosphodiesterase Activity by Vasoactive Intestinal Peptide.
30. Characterization of the antigen-induced contraction of colonic smooth muscle from sensitized guinea pigs.
31. Cyclic nucleotide-dependent protein kinases in the lower esophageal sphincter.
32. Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content.
33. Characterization of Functional Chemokine Receptors (CCR1 and CCR2) on EoL-3 Cells: A Model System to Examine the Role of Chemokines in Cell Function
34. SB 207499 (Ariflo), a Potent and Selective Second-Generation Phosphodiesterase 4 Inhibitor: In VitroAnti-inflammatory Actions
35. Inhibition of calmodulin activity by insect venom peptides
36. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A 2, on human neutrophil function
37. From genome to drug — optimising the drug discovery process
38. Quantitative structure-activity relationships of antihypertensive agents
39. Combinatorial chemistry: Polymer supported synthesis of peptide and non-peptide libraries
40. U-50,488 and the к receptor Part II: 1991–1998
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.